Oncology Drugs - Cameroon

Cameroon

The Oncology Drugs market in Cameroon is predicted to achieve a revenue of US$22.57m in 2024.
This projection indicates an annual growth rate (CAGR 2024-2029) of 6.72%, leading to a market volume of US$31.25m by 2029.
When compared globally, United States is expected to generate the highest revenue in the market, amounting to US$103,900.00m in 2024.
Cameroon's oncology drug market is witnessing a surge in research and development efforts to address the growing cancer burden in the country.

Key regions: France, Europe, United Kingdom, Brazil, India

Market

Region

Region comparison

Currency

Analyst Opinion

The Oncology Drugs market in Cameroon has been steadily growing in recent years, driven by a combination of increasing demand and favorable macroeconomic factors in the region.

Customer preferences: Cameroon has a rapidly growing population, with an increasing number of individuals seeking treatment for cancer. With a rising middle class and increasing healthcare access, demand for oncology drugs has been on the rise in recent years. Additionally, there is a growing preference for targeted therapies that offer more personalized treatment options.

Trends in the market: The Oncology Drugs market in Cameroon has seen a shift towards targeted therapies, which offer greater efficacy and fewer side effects than traditional chemotherapy. This trend is expected to continue as more targeted therapies become available and as healthcare providers become more familiar with their use. Additionally, there is a growing trend towards the use of immunotherapies, which harness the body's own immune system to fight cancer.

Local special circumstances: One of the major challenges facing the Oncology Drugs market in Cameroon is the lack of healthcare infrastructure in the country. Many patients lack access to basic healthcare services, let alone advanced cancer treatments. Additionally, there is a lack of trained healthcare professionals in the region, which makes it difficult to deliver high-quality care to patients.

Underlying macroeconomic factors: Cameroon has experienced strong economic growth in recent years, which has helped to drive demand for oncology drugs. Additionally, the government has made healthcare a priority, investing in infrastructure and increasing access to healthcare services. These factors, combined with a growing population and increasing healthcare access, are expected to continue to drive growth in the Oncology Drugs market in Cameroon in the coming years.

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.

Modeling approach / Market size:

Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.